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Aim: To describe how patients with COPD, heart failure, dementia and cancer differ in fre-
quency and timing of referral to palliative care services.
Methods: We performed a population-based study with the Sentinel Network of General Prac-
titioners in Belgium. Of 2405 registered deaths respectively 5%, 4% and 28% were identified as
from COPD, heart failure or cancer and 14% were diagnosed with severe dementia. GPs re-
ported use and timing of palliative care services and treatment goals in the final three months
of life.
Results: Patients with COPD (20%) were less likely than those with heart failure (34%), severe
dementia (37%) or cancer (60%) to be referred to palliative care services (p < 0.001). The me-
dian days between referral and death was respectively 10, 12, 14 and 20. Patients with COPD
who were not referred more often received treatment with a curative or life-prolonging goal
and less often with a palliative or comfort goal than did the other patients who were not
referred.b.ac.be (K. Beernaert).
3 Elsevier Ltd. All rights reserved.
3.06.003
1732 K. Beernaert et al.Conclusion: Patients with COPD are underserved in terms of palliative care compared to those
with other chronic life-limiting diseases. Awareness of palliative care as an option for patients
with COPD needs to increase in palliative care services, physicians and the general public.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Palliative care services have been demonstrated to improve
the end of life of people suffering from chronic life-limiting
illness [1,2]. Recent studies have also found that earlier
referrals to palliative care improve quality of life [3,4].
Although chronic obstructive pulmonary disease (COPD),
responsible for an increasing proportion of deaths [5], is a
chronic life-limiting disease, the scarce data for COPD pa-
tients seem to indicate that many patients do not receive
adequate palliative care which may leave them with
reduced quality of life in the final months, weeks or days
[6,7]. In contrast, patients with a cancer diagnosis rela-
tively often receive palliative care [8e12]. Part of this
inequality between disease groups is historical, due to the
initial focus of palliative care on oncology in the countries
in which it was first developed [13]; part of it is due to the
difference in disease trajectories [14]. Prognostication of
death, which often remains the basis for determining
whether a person is eligible for palliative care [15], is in
practice usually easier for cancer patients with a rapid
decline and a distinct terminal phase than for those with
conditions with a less-recognizable terminal phase e.g.
COPD, heart failure or dementia [14,16]. Previous review
studies [17,18], an interview study with informal carers [19]
and a large scale survey study with proxies [20] and with
patients [21] showed us that patients with advanced COPD
experience many palliative care needs similar to those of
advanced cancer patients, such as pain, insomnia, fatigue
and low mood [18e21]. Dyspnea was even found to be more
experienced in COPD patients than in patients with lung
cancer [19]. This indicates that COPD patients would
equally benefit from care with a palliative intent [22,23].
Research on referral to palliative care among patients with
COPD is scarce and most has been limited to specific set-
tings and small sample sizes [10,24].
Although fewer or later referrals may indicate a disad-
vantage or inequity, a lack of referral to palliative care
services does not necessarily mean the patient did not get
any form of care or treatment with a palliative or similar
intent through which their potential palliative care needs
may have been met [8]. Therefore, to evaluate and un-
derstand differences in palliative care referrals between
disease groups it would also be important to look at what
kind of care and treatments patients who are not referred
to any palliative care service are receiving.
This population-based retrospective study aims to
describe differences in the extent and timing of referrals to
palliative care services for people dying from COPD
compared with three other relevant disease groups: heart
failure, following the same disease course with a compa-
rable clinical picture, and dementia and cancer, following
different disease courses [14]. The study also describestreatment goals when not referred. The following research
questions are addressed:
1) How often are patients with COPD, heart failure, de-
mentia or cancer referred to palliative care services?
2) How long before death are these patients referred?
3) Which socio-demographic characteristics are associated
with referral and timing of referral to palliative care
services within those four disease groups?
4) What are the treatment goals for patients who were not
referred to these services in the last three months of
life?Methods
Study design
We conducted a population-based retrospective survey
studying deaths registered by a sample of general practi-
tioners (GPs) in Belgium, i.e. the existing nationwide
Belgian Sentinel Network of General Practitioners [25,26].
The Sentinel Network of General Practitioners is a relative
stable network of practices or community-based physi-
cians, operational since 1979. It has proved to be a reliable
epidemiologic surveillance system for health care data e.g.
on diabetes, stroke, cancer [27,28] and is representative
for all Belgian GPs in terms of age, sex and geographical
distribution [29,30]. In 2009 and 2010 it consisted of
respectively 161 and 142 participating practices (both solo
and group practices), covering respectively 1.8% and 1.5%
of the Belgian population.
Procedures
From 1 January 2009 to 31 December 2010 GPs registered
weekly all deaths of patients in their practice on a stan-
dardized registration form providing information about
care in the final three months of life. The registration
form was first developed in Dutch and then for-
wardebackward translated into French, as the study
covers both language regions (Flanders and Wallonia) in
Belgium. More details on this study protocol have been
published elsewhere [26].
Measurements
Referral and timing of referral to palliative care services
For each case the GP was asked to tick one or more of four
possibilities: palliative care team at home, hospital-based
palliative care team (excluding palliative care unit), inpa-
tient palliative care unit or in-house palliative care in a
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i.e. the number of days between the first referral to a
palliative care service and death.
Treatment goals
The importance of three treatment goals i.e. cure, life-
prolonging and comfort/palliation was judged by the GP for
respectively the last week of life, second to fourth week
before death and second to third month before death, on a
5-point Likert scale ranging from 1 (not at all important) to
5 (very important). Concurrence of more than one treat-
ment goal was possible in each period.
Socio-demographic and disease characteristics
GPs recorded the cause of death in a manner that is iden-
tical to that on the official death certificates in accordance
to WHO guidelines: the GP was asked to fill in the imme-
diate, intermediary and underlying causes of death. Causes
of death reported by the GPs for our survey were thor-
oughly checked and encoded (International Classification of
Diseases, 10th ed., ICD-10) by the Flemish Ministry of
Welfare, Public Health and Family, who also process the
official death certificates. Also GPs registered whether the
patient suffered from severe, mild or no dementia, age,
sex, main place of residence in the last year of life of the
patients and whether they experienced symptoms (pain,
breathing problems, feeling drowsy, feeling sad, feeling
nervous) in the last week of life.Analysis
For this study we selected only those patients who were 18
years or older and had died from COPD, heart failure,
cancer or had suffered from severe dementia. Patients
were attributed to one of four disease groups based on the
underlying cause of death (as registered by the GP and
encoded by the Ministry of Health into ICD-10 codes), and
on a question about whether the patient suffered from
severe, mild or no dementia: COPD (ICD-10 codes J40-47),
heart failure (ICD-10 codes I50, I110, I130, I132), cancer
(ICD-10 codes C00-D48) or dementia (when the GP indicated
that the patient suffered from severe dementia).
In order to explore differences between the four disease
groups for referral to palliative care services we conducted
Pearson chi square tests. Multivariate binary logistic
regression was performed to control for confounding ef-
fects of sex, age and main place of residence. We evaluated
differences between the disease groups in terms of time of
onset of referral with the non-parametric KruskaleWallis
test. We performed ordinal logistic regression to control for
confounding effects.
In order to investigate the association between referral
and age, sex and main place of residence within each dis-
ease group we performed Pearson chi2 tests as well as
multivariate binary logistic regression for each disease
separately.
To further understand the differences in referral be-
tween the disease groups we explored treatment goals for
patients who were not referred to palliative care services
using Pearson chi2 tests. All analyses were performed using
SPSS (version 19.0).Ethical considerations
Anonymity of patient and physician was preserved. The
study protocol was approved by the Ethical Review Board of
Brussels University Hospital [26].
Results
In total, GPs registered 2405 deaths of which 1197 were
from COPD, heart failure, cancer or involved severe de-
mentia (Table 1). The proportions of all deaths of the dis-
ease groups are comparable to the official death certificate
data from 2008.
Referral to palliative care services and timing of
referral
In the last three months of life patients with COPD (20%)
were less often referred to any type of palliative care
service than were those with heart failure (34%), severe
dementia (37%) or cancer (60%) (Table 2). Of all patients
with COPD, 4% were referred to a palliative care team at
home, 6% to a hospital-based palliative care team and 6% to
an inpatient palliative care unit, all less often than cancer
patients; 8% were referred to in-house palliative care in a
nursing home, which was less often than patients suffering
from dementia (25%). Multivariate logistic regression ana-
lyses confirmed the differences between the four disease
groups in the chances of referral independently of sex, age
and main place of residence.
Patients with COPD had a lower median number of days
between referral and death (10 days) than those with heart
failure (12 days), dementia (14 days) and cancer (20 days).
However, this difference was not significant when
controlled for sex, age and main place of residence.
Socio-demographic characteristics associated with
referral within the four disease groups
Female cancer patients were more likely to be referred to
palliative care services than their male counterparts. Pa-
tients with heart failure and dementia were more likely to
be referred when they lived in a nursing home than when
they lived at home, while the opposite was found for cancer
patients. No significant associations were found in the
multivariate analyses for patients with COPD (Table 3).
There were no significant associations between socio-
demographic characteristics and the timing of onset of
palliative care services for the four disease groups (not in
table).
Treatment goals for patients not referred to
palliative care services
The proportion of patients not referred decreased as death
approached. This was the case for all disease groups
(Fig. 1). Of those not referred, patients with COPD received
fewer treatments aimed at comfort/palliation than did
other patients. Even in the last week of life 40% of patients
with COPD were not given treatment with comfort or
Table 1 Sample characteristics of deceased patients with COPD, heart failure, severe dementia and cancer (%).
Number (% of all deaths) COPD
111 (4.6)
Heart failure
N Z 88 (3.7)
Dementia
N Z 325 (13.5)
Cancer
N Z 673 (28.0)
p-value
Sex <0.001a
Male 62.7 39.8 35.2 56.3
Age at death, in years <0.001a
18e64 y 7.2 2.3 2.5 27.2
65e84 y 63.1 33.0 38.9 53.7
85 y 29.7 64.8 58.6 19.0
Main residence last year of life <0.001a
Home 71.2 54.5 31.9 88.5
Nursing home 27.9 42.0 65.6 9.4
Other institute 0.9 3.4 2.5 2.1
Symptoms in last week of lifeb
Pain 29.1 27.0 30.8 55.4 <0.001a
Breathing problems 88.4 75.3 46.1 56.3 <0.001a
Feeling drowsy 54.4 52.0 69.7 76.0 <0.001a
Feeling nervous 48.9 34.8 20.1 44.6 <0.001a
Feeling sad 44.7 30.9 18.2 56.2 <0.001a
Percentages are column percentages.
Other institute comprised (psychiatric) hospitals, rehabilitation center or monastery.
Symptoms in the last week of life were rated as present (yes) or not present (no) by the GP.
Eleven patients with COPD as an underlying cause of death also suffered from dementia and were allocated to the COPD group as this
disease is the focus of our study.
Proportions of cause of death of all deaths from our study (n Z 2405) were compared with the proportion of cause of death from the
most recent official death certificate data (2008) in Belgium (n Z 101685). The proportions in the latter were for COPD 4.5%, heart
failure 4.4% and cancer 27.1%.
a Pearson c2 test testing for differences between the four disease groups.
b Missing values: for pain nZ 193 (16%); for breathing problems nZ 171 (14%); for feeling drowsy nZ 179 (15%); for feeling nervous
n Z 286 (24%); for feeling sad n Z 314 (26%).
1734 K. Beernaert et al.palliative intent. Patients with COPD more often received
treatment aimed at cure and at life-prolonging throughout
the last three months, up to the last week of life, than
those with heart failure, dementia and cancer.Discussion
This retrospective study shows that patients with COPD
(20%) were much less likely than those with heart failure
(34%), severe dementia (37%) or cancer (60%) to be referred
to any palliative care service. All patients were referred
relatively late in the disease course. Patients with COPD
who were not referred more often received treatment with
a curative or life-prolonging goal and less often with palli-
ative or comfort intent than did those with heart failure,
dementia or cancer who were not referred.
To our knowledge this is the first study comparing the
extent and timing of referral to palliative care services, as
well as treatment goals of those not referred, for people
with COPD, heart failure, dementia and cancer. Our
retrospective design and the use of an established repre-
sentative GP network allowed us to describe these differ-
ences on a population-based level in a representative
sample of all deaths in Belgium. While retrospective designs
may have their limitations to resurrect certain aspects of
the treatment histories of dead patients [31] it is the most
appropriate design to make population-based estimates
about who received palliative care [32,33]. This study alsohas several limitations. Inherent to retrospective designs,
memory bias cannot be excluded. However, we limited
recall bias by weekly registrations, leaving little time be-
tween death and registration [34]. Another possible weak-
ness is that although GPs are often the main treating and
coordinating physicians of patients nearing the end of life,
they may not always fully be aware of all treatments and
care their patients receive in the last months of life,
particularly in institutional settings. With a low number of
patients with COPD and heart failure referred statistical
power for subanalyses for those patients (e.g. timing of
referral) was low. While more disease groups are probably
eligible for palliative care services [23] we chose to
compare COPD patients with patient groups representing
one of three typical end-of-life disease trajectories iden-
tified as eligible for palliative care in previous studies
[14,16]. We did not measure whether patients or their
families had expressed a preference for palliative care and
it could well be that such preferences is one of the reasons
(but not necessarily therefore a justification) for the un-
equal chances between disease groups of receiving pallia-
tive care. Additionally it should be kept in mind that
patterns of referral are not necessarily a good basis on
which to make inferences about the quality and appropri-
ateness of the individual care needs of patients [35].
Our study shows that palliative care services still serve
mainly cancer patients in comparison with others [9,12,23],
despite the World Health Organisation [36] calling for
palliative care for all chronic life-limiting diseases and the
Table 2 Referral to and time of onset of palliative care services in the last three months of life for the four disease gr ps
COPD
N Z 111
Heart Failure
N Z 88
Dementia
N Z 325
Cancer
N Z 673
p-value
% OR (95% CI)d % OR (95% CI)d % OR (95% CI) % OR (95% CI)d
Referral to palliative
care services (any type)
20.0 Ref cat 34.1 1.99 (1.02e3.90) 37.4 2.32 (1.34e .02) 60.3 6.07 (3.64e10.13) <0.001b
Palliative care support at home 3.6 Ref cat 5.9 1.55 (0.37e6.49) 6.0 2.61 (0.85e 04) 28.7 8.56 (3.08e23.76) <0.001b
Hospital-based palliative care
service (excl. palliative care unit)
5.5 Ref cat 3.5 0.73 (0.17e3.05) 3.5 0.85 (0.29e 47) 20.3 3.53 (1.50e8.32) <0.001b
Palliative care unit 5.5 Ref cat 7.1 1.64 (0.50e5.40) 2.8 0.68 (0.23e 07) 21.7 4.06 (1.73e9.54) <0.001b
In-house PCS in a nursing home 8.2 Ref cat 21.2 2.23 (0.85e5.83) 26.4 2.41 (1.08e .40) 6.1 1.49 (0.64e3.45) <0.001b
Time of onset of palliative
care servicesa
Median
(P25e75)
OR (95% CI)e Median
(P25e75)
OR (95% CI)e Median
(P25e75)
OR (95% CI) Median
(P25e75)
OR (95% CI)d p-value
Days prior to death 10 (7e30) Ref cat 12 (6e35) 1.34 (0.58e3.09) 14 (7e30) 0.92 (0.31e 72) 20 (8e45) 1.20 (0.48e2.99) <0.05c
Abbreviations: Ref cat Z reference category; OR Z odds ratio; CI Z confidence interval; P25e75 Z percentile 25 to 75.
Percentages are column percentages. Percentages may not add up to total percentage of referrals because more than one pallia e care service was used in some cases.
a Calculations for only patients with a referral to palliative care services.
b Pearson c2 test testing for differences in referral between the three disease groups.
c KruskaleWallis test testing for differences in time of onset between the four disease groups.
d Odds ratios with 95% confidence intervals from multivariate binary logistic regression analyses with palliative care servi as
dependent variable (referral vs no referral). Controlled for sex, age and main place of residence. Bold denotes significant difference ith
COPD at p < 0.05.
e Odds ratios with 95% confidence intervals from ordinal logistic regression analyses with time of onset of palliative care servi s as
dependent variable (ordinal variable with 3 categories: 1e7 days (ref), 2e4 weeks and 2 or more months). Controlled for sex, ag and
main place of residence.
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Table 3 Proportiona and chancesb of referrals to palliative care services by socio-demographic characteristics for the four
disease groups
COPD
N Z 111
Heart failure
N Z 88
Dementia
N Z 325
Cancer
N Z 673
Referred (%) OR (95% CI) Referred (%) OR (95% CI) Referred (%) OR (95% CI) Referred (%) OR (95% CI)
Sex
Male 19.1 Ref cat 36.4 Ref cat 31.2 Ref cat 57.7 Ref cat
Female 22.0 1.26
(0.46e3.51)
32.7 0.49
(0.16e1.48)
40.9 1.49
(0.88e2.53)
63.5 1.46
(1.05e2.05)
Age
18e64 y 25.0 Ref cat 0 Ref cat 25.0 Ref cat 62.6 Ref cat
65e84 y 17.4 0.60
(0.11e3.40)
33.3 n.a. 39.8 1.90
(0.36e10.05)
60.5 0.96
(0.65e1.42)
85 y 24.2 1.03
(0.16e6.54)
35.7 n.a. 36.6 1.42
(0.27e7.49)
54.9 0.83
(0.50e1.38)
Main residence last year of life
Home/with
family
20.5 Ref cat 23.9 Ref cat 28.3 Ref cat 61.7 Ref cat
Nursing home 16.1 0.62
(0.19e2.00)
44.4 3.33
(1.07e10.43)
41.6 1.75
(1.02e2.99)
47.5 0.55
(0.31e0.99)
Abbreviations: OR Z odds ratio; CI Z confidence interval; Ref cat Z reference category; n.s. Z not significant.
Percentages and odds ratios of patients being referred to palliative care services for each disease separately.
Bold denotes significant at p < 0.05.
a Pearson c2 test testing for differences in referral between characteristics for each disease group.
b Multivariate binary logistic regression analyses with palliative care services as dependent variable (referral vs no referral) and sex.
Age and main place of residence as independent variables.
1736 K. Beernaert et al.Belgian law on palliative care which gives equal rights to all
patients to use palliative care services and regulates its
equal availability across the country [37]. The historical
focus on cancer and the easier predictability of the cancer
disease trajectory may explain the emphasis on cancer
[38], but it is particularly remarkable that COPD, with dis-
ease symptoms and a trajectory comparable to heart fail-
ure and an unpredictable prognosis comparable to
dementia, has a significantly lower proportion of referrals
than do those patient groups and differs a great deal in
terms of treatment goals at the end of life. A possible
explanation is that many patients with COPD and their
caregivers do not consider the disease to be life-
threatening or to be suitable for palliative care [39,40].
As a result, curative or life-prolonging treatments more
often are continued until the last days of life in patients
with COPD [41]. Even when treatment is not primarily
curative or life-prolonging, the absence of noninvasive
ventilation in many palliative care settings [6], as opposed
to in pulmonology wards [42], may additionally lead phy-
sicians to less often consider referring patients with COPD
to palliative care services.
Although palliative care services have been shown to
improve the quality of care [3], not all patients need
specialized care and it would be unrealistic to refer all
patients with a life-limiting chronic disease to palliative
care services [43]. Many palliative care needs can be
managed by GPs or respiratory specialists. Our findings,
however, show that people with COPD are less likely than
those with other chronic life-limiting diseases to receive
generalist treatment with a palliative or comfort intent.
There is evidence that COPD patients experience similar
palliative care needs in their last months of life to patientswith other chronic life-limiting diseases such as cancer
[19,21]; we found high frequencies of pain, feelings of
drowsiness and sadness and even higher frequencies of
nervousness and difficulties breathing in the last week of
life, which suggests referral to a palliative care service or
at least changing treatment to include palliative or comfort
intents may be of benefit to them [7,14,44,45].
Another important finding, applicable to all disease
groups but perhaps most particularly so for COPD patients,
is that palliative care is still seen mainly as terminal care.
Half of the referred patients were referred to a palliative
care service less than 10e20 days before death. This is
considerably shorter than the time between referral and
death found in studies of cancer patients in the US (42 days)
and Australia (54 days) [46,47]. These late referrals may
imply that the services used did not have time enough to
achieve the goals of palliative care [36]. An over-optimistic
prognosis and the attitude of physicians and patients to
their disease [38,39], in combination with a reimbursement
criterion in Belgium that stipulates that a ‘palliative pa-
tient’ should have a predicted survival time of less than
three months, may impede early referral to palliative care.
These barriers may apply particularly to COPD patients.
People with COPD receive palliative care less often than
those with other chronic life-limiting diseases, both in
terms of referral to specialist palliative care services and in
terms of receiving generalist care aimed at comfort. An
increasing awareness of palliative care services as an option
for COPD patients is needed. However, bearing in mind that
involving specialist palliative care services may not neces-
sarily be required or realistic for every patient with a
chronic life-limiting disease it is also particularly important
that palliative care expertise and knowledge is cascaded to
Figure 1 Proportion of patients not referred to palliative care services and their treatment goals* over the course of the last
three months of life (%). Missing values (not responded) for comfort/palliation, life-prolonging and cure in month 2e3, week 2e4
and the last week ranged from 9% to 11%. y Percentages of patients that were not referred to any palliative care service at the time
given. z Percentages of patients for which GP indicated a score of 4 or 5 on a 5-point Likert scale ranging from 1 (not at all
important) to 5 (very important) for the question: ‘How important were the following aspects of patients care according to you?’
are displayed. These results are for patients that were not referred to palliative care services at the time given. Multiple treatment
goals were possible per period. Differences between disease groups for each treatment goal and for proportion of referral for each
time category were calculated using Pearson c2 test. All p-values were significant p < 0.01
Referral to palliative care in COPD patients 1737professional groups such as GPs and respiratory physicians.
By combining the skills of general practitioners, respiratory
physicians and palliative care services, the care of patients
with COPD can be advanced.Funding
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